Attitudes and beliefs of family physicians and gynecologists in relation to the prevention and treatment of osteoporosis

Journal of Bone and Mineral Research

Volumn 12, Issue 7, 1997, Pages 1100-1107

  Suarez Almazor, Maria ^a   Homik, Joanne E ^a   Messina, Daniel ^b   Davis, Paul ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b HOSPITAL GENERAL DE AGUDOS DR COSME ARGERICH   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CALCIUM; ESTROGEN; FLUORIDE SODIUM; PROGESTERONE; VITAMIN D;

ARTICLE; BONE DENSITY; BONE MINERALIZATION; FRACTURE; GENERAL PRACTITIONER; HORMONE SUBSTITUTION; HUMAN; KINESIOTHERAPY; MEDICAL SPECIALIST; PHYSICIAN ATTITUDE; POSTMENOPAUSE OSTEOPOROSIS; PRIMARY MEDICAL CARE; RISK FACTOR;

ALBERTA; ATTITUDE; BONE DENSITY; CLINICAL COMPETENCE; DATA COLLECTION; ESTROGEN REPLACEMENT THERAPY; FAMILY PRACTICE; FEMALE; GYNECOLOGY; HUMANS; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL;

EID: 0030914072     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.1997.12.7.1100     Document Type: Article

References (47)

1. Gallagher JC, Goldgar D, Moy A 1987 Total bone calcium in normal women: Effect of age and menopause status. J Bone Miner Res 2:491-496.
2. Lindsay R, Hart DM, Aitken JM, MacDonald EB, Anderson JB, Clarke AC 1976 Long-term prevention of postmenopausal osteoporosis by oestrogen: Evidence for an increased bone mass after delayed onset of oestrogen treatment. Lancet 1:1038-1041.
3. Genant HK, Cann CE, Ettinger B, Gordan GS 1982 Quantitative computed tomography of vertebral spongiosa: A sensitive method for detecting early bone loss after oophorectomy. Ann Intern Med 97:699-705.
4. Nordin BE, Need AG, Bridges A, Horowitz M 1992 Relative contributions of years since menopause, age, and weight to vertebral density in postmenopausal women. J Clin Endocrinol Metab 74:20-23.
5. Riggs BL 1991 Overview of osteoporosis. West J Med 154:63-77.
6. Riis B, Thomsen K, Christiansen C 1987 Does calcium supplementation prevent postmenopausal bone loss? A double-blind, controlled clinical study. N Engl J Med 316:173-177.
7. Mattsson LA, Stadberg E, Milsom I 1996 Management of hormone replacement therapy: The Swedish experience. Eur J Obstet Gynecol Repro Biol 64:S3-S5.
8. Limouzinlamothe MA 1996 What women want from hormone replacement therapy: Results of an international survey. Eur J Obstet Gynecol Repro Biol 64:S21-S24.
9. Salamone LM, Pressman AR, Seeley DG, Cauley JA 1996 Estrogen replacement therapy: A survey of older women's attitudes. Arch Intern Med 156:1293-1297.
10. Barentsen R 1996 The climacteric in the Netherlands: A review of Dutch studies on epidemiology, attitudes and use of hormone replacement therapy. Eur J Obstet Gynecol Repro Biol 64:S7-S11.
11. Rubin SM, Cummings SR 1992 Results of bone densitometry affect women's decisions about taking measures to prevent fractures. Ann Intern Med 116:990-995.
12. Cummings SR, Black DM, Rubin SM 1989 Lifetime risks of hip, Colles', or vertebral fracture and coronary heart disease among white postmenopausal women. Arch Intern Med 149:2445-2448.
13. Campbell-Brown M, McEwan HP 1992 Scottish gynaecologists: Their views on hormone replacement therapy. Health Bull 50:248-251.
14. Lip G, Beevers M, Churchill D, Beevers DG 1995 Do clinicians prescribe HRT for hypertensive postmenopausal women? Br J Clin Practice 49:61-64.
15. Hemminki E, Topo P, Malin M, Kangas I 1993 Physicians' views on hormone therapy around and after menopause. Maturitas 16:163-173.
16. Norman SG, Studd JW 1994 A survey of views on hormone replacement therapy. Br J Obstet Gynaecol 101:879-887.
17. Greendale GA, Carlson KJ, Schiff I 1990 Estrogen and progestin therapy to prevent osteoporosis: Attitudes and practices of general internists and gynecologists. J Gen Intern Med 5:464-469.
18. Grisso JA, Baum CR, Turner BJ 1990 What do physicians in practice do to prevent osteoporosis? J Bone Miner Res 5:213-219.
19. Wilkes HC, Meade TW 1991 Hormone replacement therapy in general practice: A survey of doctors in the MRC's general practice research framework see comments. Br Med J 302:1317-1320.
20. Backe B, Hunskaar S, Skolbekken JA 1992 General practitioners' attitudes to oestrogen prescription in the menopause: A national survey in Norway. Scand J Prim Health Care 10:179-184.
21. Bryce FC, Lilford RJ 1990 General practitioners use of hormone-replacement therapy in Yorkshire. Eur J Obstet Gynecol Repro Biol 37:55-61.
22. Anonymous 1987 Consensus development conference: Prophylaxis and treatment of osteoporosis. Br Med J Clin Res Ed 295:914-915.
23. Delva MD 1993 Hormone replacement therapy: Risks, benefits, and costs. Can Fam Phys 39:2149-2154.
24. Lufkin EG, Wahner HW, O'Fallon WM, et al. 1992 Treatment of postmenopausal osteoporosis with transdermal estrogen. Ann Intern Med 117:1-9.
25. Grey AB, Cundy TF, Reid IR 1994 Continuous combined oestrogen/progestin therapy is well tolerated and increases bone density at the hip and spine in post-menopausal osteoporosis. Clin Endocrinol 40:671-677.
26. Marx CW, Dailey GE III, Cheney C, Vint VC II, Muchmore DB 1992 Do estrogens improve bone mineral density in osteoporotic women over age 65? J Bone Miner Res 7:1275-1279.
27. Ott SM 1992 Estrogen therapy for osteoporosis - Even in the elderly. Ann Intern Med 117:85-86.
28. Holland EF, Leather AT, Studd JW 1995 Increase in bone mass of older postmenopausal women with low mineral bone density after one year of percutaneous oestradiol implants. Br J Obstet Gynaecol 102:238-242.
29. Rieder A, Schwarz B, Kunze M 1993 Osteoporosis: Attitudes and opinions of Austrian physicians. Wien Med Wochenschr 143:307-311.
30. Cummings SR, Black D 1986 Should perimenopausal women be screened for osteoporosis? Ann Intern Med 104:817-823.
31. Ott S 1986 Should women get screening bone mass measurements? Ann Intern Med 104:874-876.
32. Hall FM, Davis MA, Baran DT 1987 Bone mineral screening for osteoporosis. N Engl J Med 316:212-214.
33. Rosenthal DI, Tosteson AN 1989 Bone mass measurement, fracture risk, and screening for osteoporosis. Public Health Rep 104 (Suppl):31-33.
34. Riggs BL, Wahner HW 1988 Bone densitometry and clinical decision-making in osteoporosis. Ann Intern Med 108:293-295.
35. Melton LJ III, Eddy DM, Johnston CC Jr 1990 Screening for osteoporosis. Ann Intern Med 112:516-528.
36. Cummings SR, Black DM, Nevitt MC, et al. 1990 Appendicular bone density and age predict hip fracture in women: The Study of Osteoporotic Fractures Research Group. JAMA 263:665-668.
37. Hui SL, Slemenda CW, Johnston CC Jr 1989 Baseline measurement of bone mass predicts fracture in white women. Ann Intern Med 111:355-361.
38. Gardsell P, Johnell O, Nilsson BE 1989 Predicting fractures in women by using forearm bone densitometry. Calcif Tissue Int 44:235-242.
39. Hui SL, Slemenda CW, Johnston CC Jr 1988 Age and bone mass as predictors of fracture in a prospective study. J Clin Invest 81:1804-1809.
40. Anonymous 1989 Clinical indications for bone mass measurements: A report from the Scientific Advisory Board of the National Osteoporosis Foundation. J Bone Miner Res 4 (Suppl 2):1-28.
41. Stevenson JC, Lees B, Devenport M, Cust MP, Ganger KF 1989 Determinants of bone density in normal women: Risk factors for future osteoporosis? Br Med J 298:924-928.
42. Slemenda CW, Hui SL, Longcope C, Wellman H, Johnston CC Jr 1990 Predictors of bone mass in perimenopausal women: A prospective study of clinical data using photon absorptiometry. Ann Intern Med 112:96-101.
43. Tosteson ANA, Rosenthal DI, Melton J III, Weinstein MC 1990 Cost effectiveness of screening perimenopausal white women for osteoporosis: Bone densitometry and hormone replacement therapy. Ann Intern Med 113:594-603.
44. Cheung A, Wren B 1992 A cost-effectiveness analysis of hormone replacement therapy in the menopause. Med J Austr 156:312-316.
45. Ryan PJ, Harrison R, Blake GM, Fogelman I 1992 Compliance with hormone replacement therapy (HRT) after screening for post menopausal osteoporosis. Br J Obstet Gynaecol 99:325-328.
46. Hammond CB, Jelovsek FR, Lee KL, Creasman WT, Parker RT 1979 Effects of long-term estrogen replacement therapy. II. Neoplasia. Am J Obstet Gynecol 133:537-547.
47. Seto TB, Taira DA, Davis RB, Safran C, Phillips RS 1996 Effect of physician gender on the prescription of estrogen replacement therapy. J Gen Intern Med 11:197-203.